Molecular Axiom
微哲默理
Molecular Axiom
Biotech/Healthcare
Molecular Axiom focuses on the discovery, clinical development, and commercialization of nucleic acid therapeutics. Its core capabilities span multiple RNA technology platforms, including ASO, RNAi, and mRNA, as well as drug delivery technologies such as LNPs.
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.